USPTO serial 79417423
AVANTI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CROWDER-SCHAEFER, ANDREW W
- Law office
- TMEG LAW OFFICE 104
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with AVANTI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical compounds for scientific or research use; lipid compounds for scientific or research use; adjuvants, polymers and excipients, including surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for scientific or research use; transfection reagents for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; standard solutions for use with analytical techniques, namely, mass spectrometry; lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles; fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, for scientific or research use; diagnostic and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; fluorophores and fluorescent probes for scientific or research use; chemical auxiliary agents as raw materials for manufacturing pharmaceutical preparations, nutrient preparations, and food supplements. | ACTIVE | — |
| 005 | Lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, active agents, additives, and excipients in pharmaceutical preparations; adjuvants, polymers and excipients, including surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for pharmaceutical or medical use; immunostimulatory compounds for pharmaceutical or medical use; isotopes for medical use; transfection reagents for pharmaceutical or medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, for pharmaceutical or medical use; drug delivery auxiliary agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals. | ACTIVE | — |
| 009 | Apparatus and instruments for scientific research in laboratories. | ACTIVE | — |
| 040 | Manufacturing services for others in the field of active agents, additives, or excipients for pharmaceutical preparations; manufacturing services for others in the field of lipids; cGMP manufacture of active agents, additives, or excipients, for others; cGMP manufacture of lipids, for others; manufacturing services for others in the field of active agents, additives, or excipients in pharmaceutical preparations; manufacturing services for others in the field of lipids. | ACTIVE | — |
| 042 | Analytical laboratory services; scientific research for medical purposes; analytical laboratory services in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; research and development and consultation related thereto in the field of pharmaceuticals and chemicals; research services for others; research services for others in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; lipidomics services, namely analytical services relating to lipid metabolism in biological systems; cGMP testing services; formulation chemistry services in the field of pharmaceuticals, lipids, and chemicals; providing information relating to lipids and related compounds for scientific and medical research purposes. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Croda International Plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named AVANTI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 21, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 21, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 6, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 19, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 9, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 21, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 21, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 26, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 9, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 8, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 4, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 3, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |